A 69-year-old ex-smoker with a 40 pack-year history has COPD with mMRC dyspnoea grade 2 and one mild exacerbation last year managed in the community. He is not on inhaled therapy. According to the 2023 Canadian Thoracic Society COPD pharmacotherapy guideline, what is the most appropriate initial maintenance therapy?